61 - Lupus Erythematosus Flashcards

1
Q

The term LE-specific relates to those lesions displaying a/an

A

Interface dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most frequent clinical manifestation of LE

A

Joint inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Second most frequent clinical manifestation of LE

A

Skin disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACLE

A
  1. Localized ACLE (malar rash, butterfly rash)
  2. Generalized ACLE (lupus maculopapular rash, SLE rash, photosensitive lupus dermatitis)
    a. TEN-like ACLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SCLE

A
  1. Annular SCLE
  2. Papulosquamous SCLE

*Drug-induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CCLE

A
  1. Classic DCLE
    a. Localized DLE
    b. Generalized DLE
  2. Hypertrophic/verrucous DLE
  3. Lupus profundus/lupus panniculitis
  4. Mucosal DLE
  5. Oral DLE
  6. Conjunctival DLE
  7. Lupus tumidus (urticarial plaque phase of LE)
  8. Chillblain LE (chillblain lupus, perniotic lupus)
  9. Lichenoid DLE (LE/lichen planus overlap, lupus planus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fixed erythema, flat or raised, over the malar eminences, tending to spare the nasolabial folds

A

Malar rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Erythematous raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring may occur in older lesions

A

Discoid rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Skin rash as a result of unusual reaction to sunlight, by patient history or physician observation

A

Photosensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oral ulcers: oral or nasopharyngeal ulceration, usually (painful/painless), observed by a physician

A

Painless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Serositis criteria

A

a. Pleuritis - convincing history of pleuritic pain or rub heard by a physician or evidence of pleural effusion
or
b. Pericarditis - documented by electrocardiogram or rub or evidence of pericardial effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Renal disorder criteria

A

a. Persistent proteinuria - >0.5 g/day or greater than 3+ if quantitation not performed
or
b. Cellular casts - may be red cell, hemoglobin, granular, tubular, or mixed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neurologic disorder criteria

A

a. Seizures - in the absence of offending drugs or known metabolic derangements (eg, uremia, ketoacidosis, or electrolyte imbalance)
or
b. Psychosis - in the absence of offending drugs or known metabolic derangements (eg, uremia, ketoacidosis, or electrolyte imbalance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hematologic disorder criteria

A

a. Hemolytic anemia - with reticulocytosis
or
b. Leukopenia - < 4000 μL total on 2 or more occasions
or
c. Lymphopenia - < 1500/μL on 2 or more occasions
or
d. Thrombocytopenia - < 100,000 μL in the absence of offending drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immunologic disorder criteria

A

a. Anti-DNA - antibody to native DNA in abnormal titer
or
b. Anti-Smith antigen - presence of antibody to Smith nuclear antigen
or
c. Positive finding of antiphospholipid antibodies based on (1) an abnormal serum level of igG or igM anticardiolipin antibodies, (2) a positive test result for lupus anticoagulant using a standard method, (3) a false-positive serologic test for syphilis known to be positive for at least 6 months and confirmed by Treponema pallidum immobilization or fluorescent treponemal antibody absorption test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antinuclear antibody criteria

A

An abnormal titer of antinuclear antibody by immunofluorescence of an equivalent assay at any point in time and in the absence of drugs known to be associated with “drug-induced lupus” syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

1982 Revised Criteria for Classification of SLE: a person shall be said to have SLE if any _____ or more of the _____ criteria present

A

4

11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

_____ SCLE patients are somewhat older at disease onset

A

Drug-induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Most common form of CCLE

A

Classic DLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Approximately _____% of patients presenting with isolated localized DLE subsequently develop SLE

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Most upregulated gene pathway identified in microarray studies in SLE patients

A

Type 1 IFN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Produce large amounts of type 1 IFN in response to DNA and RNA stimulation through toll-like receptors 7 and 9

A

Plasmacytoid dendritic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Probably the most important environmental factor in the induction phase of SLE

A

UV radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Y/N: Smokers are at a greater risk of developing SLE than are nonsmoker and former smokers

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Patients with treatment-resistance CLE were much more likely to
Smoke
26
Patients with LE-specific skin disease who smoke are less responsive to
Anti-malarial treatment
27
Seroconversion to _____ virus among patients with SLE is nearly universal
Epstein-Barr virus
28
Y/N: The designations acute, subacute, and chronic, in regard to CLE, refer to how long individual lesions have been present.
No - Refer to the pace and severity of any associated SLE and are not necessarily related to how long individual lesions have been present
29
Most commonly imputed drug classes causing drug-induced lupus
Antacids Antifungals Biologics Chemotherapeutic
30
Localized ACLE has commonly been referred to as
Classic butterfly rash or | Malar rash of SLE
31
Characteristically spared in malar rash
Nasolabial folds
32
Generalized ACLE presents as a widespread morbilliform or exanthematous eruption often focused over the extensor aspects of the arms and hands and characteristically sparing the
Knuckles
33
Perivascular nail fold erythema and telangiectasia are considerably more common and occur in more exaggerated forms of
Dermatomyositis | Systemic sclerosis
34
An extremely acute form of ACLE is rarely seen that can simulate
Toxic epidermal necrolysis
35
ACLE can be differentiated from true TEN because it
Occurs on predominantly sun-exposed skin | Has a more insidious onset
36
A finding of circulating autoantibodies to the _____ strongly supports a diagnosis of SCLE
Ro/SS-A ribonucleoprotein particle
37
Erythema multiforme-like lesions occurring in patients with SLE in the presence of La/SS-B autoantibodies
Rowell syndrome
38
When the face is involved with SCLE, it is most often the _____, with sparing of the _____
Lateral face | Central, malar regions
39
A consistent clinical difference is that DLE lesions are characteristically _____, whereas SCLE lesions are not
Indurated
40
Risk factors for the development of SLE in a patient presenting with SCLE lesions
Papulosquamous type of SCLE Leukopenia High titer of ANA (>1:640) anti-dsDNA antibodies
41
When the adherent scale is lifted from more advanced DLE lesions, keratotic spikes similar in appearance to _____ can be seen to project from the undersurface of the scale
Carpet tacks
42
May represent telogen effluvium occurring as the result of flaring systemic disease
Lupus hair
43
Y/N: LE skin disease activity can be precipitated by any form of cutaneous trauma
Yes - Koebner phenomenom or isomorphic effect
44
Perforation of the nasal septum is more often associated with _____ than DLE
SLE
45
Kaposi-Irrgang disease
LE profundus/LE panniculitis
46
Chillblain LE appears to be associated with _____ antibodies
anti-Ro/SS-A
47
Helps to distinguish chillblain LE from idiopathic chillblains
Persistence of lesions beyond the cold months Positive ANA Presence of one of the other ACR criteria for SLE
48
Y/N: The characteristic epidermal histologic changes of LE-specific skin disease are only minimally expressed, if at all in lupus erythematosus tumidus
Yes
49
Most photosensitive subtype of cutaneous lupus
Lupus erythematosus tumidus
50
Y/N: Lupus erythematosus tumidus typically demonstrates a poor response to antimalarials
No - good response
51
Y/N: Lupus erythematosus tumidus lesions tend to resolve completely without either scarring or atrophy
Yes
52
The presence of LE-nonspecific skin changes, especially when seen in conjunction with LE-specific rashes, corresponds with
Higher systemic disease activity
53
The laboratory markers for SCLE are the presence of _____ (70% - 90%) and, less commonly, _____ (30% - 50%) autoantibodies
Anti-Ro/SS-A | Anti-La/SS-B
54
Approximately _____% of the patients with SCLE develop active SLE
10
55
Evidence suggests that overlap occurs between SCLE and
Sjogren syndrome
56
First line treatment for LE-specific skin disease
Topical glucocorticoids, topical calcineurin inhibitor | Intralesional triamcinolone acetonide
57
Second line treatment for LE-specific skin disease
Hydroxychloroquine Chloroquine Quinacine If monotherapy fails, add quinacrine to either hydroxychloroquine or chloroquine
58
Short course treatment (2-16 weeks only) for LE-specific skin disease
Prednisone | Thalidomide
59
Third line treatment for LE-specific skin disease
Azathioprine Mycophenolate mofetil Methotrexate
60
Maximum dose of hydroxychloroquine
6.5 mg/kg/day based on ideal body weight
61
Maximum dose of chloroquine
3-4 mg /kg/day
62
Approximately _____ are required to reach equilibrium blood levels of hydroxychloroquine
6 weeks
63
If no response is seen after _____ of hydroxychloroquine, quinacrine hydrochloride 100 mg/day can be added
8-12 weeks
64
Antimalarial that does not cause retinopathy
Quinacrine
65
Doses of _____ may need to be adjusted for patients with decreased renal or hepatic function
Quinacrine
66
Chloroquine is generally felt to be more efficacious than hydroxychloroquine in treating CLE, perhaps because of the
Earlier therapeutic responds that might occur as a result of the shorter time period required to reach steady-state blood levels
67
Should not be used simultaneously because of the enhanced risk of retinal toxicity
Hydroxychloroquine | Chloroquine
68
(Hydroxychloroquine/Chloroquine) may be more retinotoxic than (Hydroxychloroquine/Chloroquine)
Chloroquine | Hydroxychloroquine
69
Y/N: Modern hydroxychloroquine regimen can be used safely in children and in women who are pregnant
Yes
70
Antimalarial associated with higher incidence of side effects
Quinacrine
71
Commonly produces a yellow discoloration of the entire skin and sclera in fair-skinned individuals, which is completely reversible when the dose of the drug is reduced or discontinued altogether
Quinacrine
72
Can produce significant hemolysis in patients with G6PD deficiency
Quinacrine
73
Can produce bone marrow suppression, including aplastic anemia, although this effect is exceedingly rare with the current dosage regimens
Each of the aminoquinolone antimalarials
74
Significant dose-related and/or methemoglobinemia can result from the use of
Dapsone
75
Sensory neuropathy is another toxicity associated with _____, and 25% to 75% of patients with CLE develop peripheral neuropathy while taking this drug
Thalidomide
76
Thromboembolism is a serious adverse event that may occur in patients with a preexisting hypercoagulable state
Thalidomide
77
Thalidomide analog | US FDA approved for the treatment of multiple myeloma
Lenalidomide
78
Safety data to date indicates a much lower rate of peripheral neuropathy with (thalidomide/lenalidomide) compared to (thalidomide/lenalidomide); however it has a similar rate of thromboembolism (especially when combined with glucocorticoids) and leukopenia compared to (thalidomide/lenalidomide)
Lenolidomide Thalidomide Thalidomide
79
Because steroid-induced bone loss occurs most rapidly in the first _____ of use, all patients who do not have contraindications should begin agents to prevent osteoporosis with the initiation of steroid therapy
6 months
80
(Prednisone/Prednisolone) rather than (Prednisone/Prednisolone) should be used in patients who have significant underlying liver disease, because (Prednisone/Prednisolone) requires hydroxylation in the liver to become biologically active
Prednisolone Prednisone Prednisone
81
Any amount of prednisone given as a single oral dose in the morning has (more/less) adrenal-suppressing activity than the same amount given in divided doses throughout the day
Less
82
Any given amount of prednisone, taken in divided doses, has a (greater/lesser) LE-suppressing activity than does the same amount of drug given as a single morning dose
Greater